Investor Relations
Clearside Biomedical, Inc. is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding diseases of the eye.
Stock Quote

$7.27 + 0.26 (3.71%)

CLSD (Common Stock)

Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming Events
There are currently no events scheduled.

More >>